Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Injured Podocytes Are Sensitized to Angiotensin II-Induced Calcium Signaling.

Binz-Lotter J, Jüngst C, Rinschen MM, Koehler S, Zentis P, Schauss A, Schermer B, Benzing T, Hackl MJ.

J Am Soc Nephrol. 2020 Jan 10. pii: ASN.2019020109. doi: 10.1681/ASN.2019020109. [Epub ahead of print]

PMID:
31924670
2.

Medication adherence among patients with chronic diseases: a survey-based study in pharmacies.

Jüngst C, Gräber S, Simons S, Wedemeyer H, Lammert F.

QJM. 2019 Jul 1;112(7):505-512. doi: 10.1093/qjmed/hcz058.

PMID:
30840076
3.

Selective Capture and Purification of MicroRNAs and Intracellular Proteins through Antisense-vectorized Magnetic Nanobeads.

Gessner I, Yu X, Jüngst C, Klimpel A, Wang L, Fischer T, Neundorf I, Schauss AC, Odenthal M, Mathur S.

Sci Rep. 2019 Feb 14;9(1):2069. doi: 10.1038/s41598-019-39575-7.

4.

The Cdkn1aSUPER Mouse as a Tool to Study p53-Mediated Tumor Suppression.

Torgovnick A, Heger JM, Liaki V, Isensee J, Schmitt A, Knittel G, Riabinska A, Beleggia F, Laurien L, Leeser U, Jüngst C, Siedek F, Vogel W, Klümper N, Nolte H, Wittersheim M, Tharun L, Castiglione R, Krüger M, Schauss A, Perner S, Pasparakis M, Büttner R, Persigehl T, Hucho T, Herter-Sprie GS, Schumacher B, Reinhardt HC.

Cell Rep. 2018 Oct 23;25(4):1027-1039.e6. doi: 10.1016/j.celrep.2018.09.079.

5.

Myeloid Cell-Restricted STAT3 Signaling Controls a Cell-Autonomous Antifibrotic Repair Program.

Do NN, Willenborg S, Eckes B, Jüngst C, Sengle G, Zaucke F, Eming SA.

J Immunol. 2018 Jul 15;201(2):663-674. doi: 10.4049/jimmunol.1701791. Epub 2018 Jun 13.

6.

Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset.

Schatz SB, Jüngst C, Keitel-Anselmo V, Kubitz R, Becker C, Gerner P, Pfister ED, Goldschmidt I, Junge N, Wenning D, Gehring S, Arens S, Bretschneider D, Grothues D, Engelmann G, Lammert F, Baumann U.

Hepatol Commun. 2018 Mar 22;2(5):504-514. doi: 10.1002/hep4.1149. eCollection 2018 May.

7.

A Variant of COL3A1 (rs3134646) Is Associated With Risk of Developing Diverticulosis in White Men.

Reichert MC, Kupcinskas J, Krawczyk M, Jüngst C, Casper M, Grünhage F, Appenrodt B, Zimmer V, Weber SN, Tamelis A, Lukosiene JI, Pauziene N, Kiudelis G, Jonaitis L, Schramm C, Goeser T, Schulz A, Malinowski M, Glanemann M, Kupcinskas L, Lammert F.

Dis Colon Rectum. 2018 May;61(5):604-611. doi: 10.1097/DCR.0000000000001001.

PMID:
29533249
8.

Selective association of nonaspirin NSAIDs with risk of diverticulitis.

Reichert MC, Krawczyk M, Appenrodt B, Casper M, Friesenhahn-Ochs B, Grünhage F, Jüngst C, Zimmer V, Lammert F, Dauer M.

Int J Colorectal Dis. 2018 Apr;33(4):423-430. doi: 10.1007/s00384-018-2968-z. Epub 2018 Feb 6.

PMID:
29411119
9.

Benign recurrent intrahepatic cholestasis (BRIC)-like episode associated with ATP8B1 variation underlying protracted cholestatic course of acute hepatitis E virus infection.

Zimmer V, Bohle RM, Weber SN, Lammert F, Jüngst C.

Dig Liver Dis. 2018 Feb;50(2):206-207. doi: 10.1016/j.dld.2017.10.022. Epub 2017 Nov 8. No abstract available.

PMID:
29191380
10.

E-cadherin integrates mechanotransduction and EGFR signaling to control junctional tissue polarization and tight junction positioning.

Rübsam M, Mertz AF, Kubo A, Marg S, Jüngst C, Goranci-Buzhala G, Schauss AC, Horsley V, Dufresne ER, Moser M, Ziegler W, Amagai M, Wickström SA, Niessen CM.

Nat Commun. 2017 Nov 1;8(1):1250. doi: 10.1038/s41467-017-01170-7.

11.

NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients.

Jüngst C, Stadlbauer V, Reichert MC, Zimmer V, Weber SN, Ofner-Ziegenfuß L, Voigtländer T, Spindelböck W, Fickert P, Kirchner GI, Lammert F, Lankisch TO, Krawczyk M.

Sci Rep. 2017 Aug 1;7(1):7026. doi: 10.1038/s41598-017-06268-y.

12.

The ciliary membrane-associated proteome reveals actin-binding proteins as key components of cilia.

Kohli P, Höhne M, Jüngst C, Bertsch S, Ebert LK, Schauss AC, Benzing T, Rinschen MM, Schermer B.

EMBO Rep. 2017 Sep;18(9):1521-1535. doi: 10.15252/embr.201643846. Epub 2017 Jul 14.

13.

Role of LTBP4 in alveolarization, angiogenesis, and fibrosis in lungs.

Bultmann-Mellin I, Dinger K, Debuschewitz C, Loewe KMA, Melcher Y, Plum MTW, Appel S, Rappl G, Willenborg S, Schauss AC, Jüngst C, Krüger M, Dressler S, Nakamura T, Wempe F, Alejandre Alcázar MA, Sterner-Kock A.

Am J Physiol Lung Cell Mol Physiol. 2017 Oct 1;313(4):L687-L698. doi: 10.1152/ajplung.00031.2017. Epub 2017 Jul 6.

14.

Severe drug-induced liver injury related to therapy with dimethyl fumarate.

Jüngst C, Kim YJ, Lammert F.

Hepatology. 2016 Oct;64(4):1367-9. doi: 10.1002/hep.28652. Epub 2016 Jul 4. No abstract available.

PMID:
27228386
15.

A novel multiplex bead-based platform highlights the diversity of extracellular vesicles.

Koliha N, Wiencek Y, Heider U, Jüngst C, Kladt N, Krauthäuser S, Johnston IC, Bosio A, Schauss A, Wild S.

J Extracell Vesicles. 2016 Feb 19;5:29975. doi: 10.3402/jev.v5.29975. eCollection 2016.

16.

[Prevalence and risk factors of drug induced liver disease: a survey based study in pharmacies].

Jüngst C, Gräber S, Klahn D, Wedemeyer H, Lammert F.

Z Gastroenterol. 2016 Feb;54(2):131-8. doi: 10.1055/s-0041-104024. Epub 2016 Feb 8. German.

PMID:
26854832
17.

A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.

Dietlein F, Kalb B, Jokic M, Noll EM, Strong A, Tharun L, Ozretić L, Künstlinger H, Kambartel K, Randerath WJ, Jüngst C, Schmitt A, Torgovnick A, Richters A, Rauh D, Siedek F, Persigehl T, Mauch C, Bartkova J, Bradley A, Sprick MR, Trumpp A, Rad R, Saur D, Bartek J, Wolf J, Büttner R, Thomas RK, Reinhardt HC.

Cell. 2015 Jul 2;162(1):146-59. doi: 10.1016/j.cell.2015.05.053. Erratum in: Cell. 2015 Aug 27;162(5):1169.

18.

Lipid droplets as a novel cargo of tunnelling nanotubes in endothelial cells.

Astanina K, Koch M, Jüngst C, Zumbusch A, Kiemer AK.

Sci Rep. 2015 Jun 22;5:11453. doi: 10.1038/srep11453.

19.

Secondary sclerosing cholangitis rapidly leading to liver cirrhosis: a possible post-ICU treatment sequel.

Reichert MC, Jüngst C, Grünhage F, Lammert F, Krawczyk M.

QJM. 2016 Feb;109(2):119-20. doi: 10.1093/qjmed/hcv119. Epub 2015 Jun 19. No abstract available.

PMID:
26092685
20.

Spastin binds to lipid droplets and affects lipid metabolism.

Papadopoulos C, Orso G, Mancuso G, Herholz M, Gumeni S, Tadepalle N, Jüngst C, Tzschichholz A, Schauss A, Höning S, Trifunovic A, Daga A, Rugarli EI.

PLoS Genet. 2015 Apr 13;11(4):e1005149. doi: 10.1371/journal.pgen.1005149. eCollection 2015 Apr.

21.

IAP antagonization promotes inflammatory destruction of vascular endothelium.

Witt A, Seeger JM, Coutelle O, Zigrino P, Broxtermann P, Andree M, Brinkmann K, Jüngst C, Schauss AC, Schüll S, Wohlleber D, Knolle PA, Krönke M, Mauch C, Kashkar H.

EMBO Rep. 2015 Jun;16(6):719-27. doi: 10.15252/embr.201439616. Epub 2015 Mar 30.

22.

[Improvement of cost allocation in gastroenterology by introduction of a novel service catalogue covering the complete spectrum of endoscopic procedures].

Rathmayer M, Scheffer H, Braun M, Heinlein W, Akoglu B, Brechmann T, Gölder SK, Lankisch T, Messmann H, Schneider A, Wagner M, Fleßa S, Meier A, Lewerenz B, Gossner L, Faiss S, Toermer T, Werner T, Wilke MH, Lerch MM, Schepp W; DRG-Arbeitsgruppe und das Zeiterfassungsprojekt der DGVS (Autoren im Anhang).

Z Gastroenterol. 2015 Mar;53(3):183-98. doi: 10.1055/s-0034-1399199. Epub 2015 Mar 16. German.

PMID:
25775168
23.

miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL.

Berg V, Rusch M, Vartak N, Jüngst C, Schauss A, Waldmann H, Hedberg C, Pallasch CP, Bastiaens PI, Hallek M, Wendtner CM, Frenzel LP.

Blood. 2015 May 7;125(19):2948-57. doi: 10.1182/blood-2014-07-586511. Epub 2015 Feb 10.

24.

Functionally significant, rare transcription factor variants in tetralogy of Fallot.

Töpf A, Griffin HR, Glen E, Soemedi R, Brown DL, Hall D, Rahman TJ, Eloranta JJ, Jüngst C, Stuart AG, O'Sullivan J, Keavney BD, Goodship JA.

PLoS One. 2014 Aug 5;9(8):e95453. doi: 10.1371/journal.pone.0095453. eCollection 2014.

25.

[Autoimmune hepatitis].

Jüngst C, Lammert F, Strassburg CP.

Dtsch Med Wochenschr. 2013 Dec;138(50):2599-608; quiz 2609-12. doi: 10.1055/s-0033-1349567. Epub 2013 Dec 3. Review. German. No abstract available.

PMID:
24301494
26.

Long-term live cell microscopy studies of lipid droplet fusion dynamics in adipocytes.

Jüngst C, Klein M, Zumbusch A.

J Lipid Res. 2013 Dec;54(12):3419-29. doi: 10.1194/jlr.M042515. Epub 2013 Oct 8.

27.

Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration.

Jüngst C, Krämer J, Schneider G, Lammert F, Zimmer V.

Ann Hepatol. 2013 Sep-Oct;12(5):834-6.

28.

Intrahepatic cholestasis in common chronic liver diseases.

Jüngst C, Berg T, Cheng J, Green RM, Jia J, Mason AL, Lammert F.

Eur J Clin Invest. 2013 Oct;43(10):1069-83. doi: 10.1111/eci.12128. Epub 2013 Aug 8. Review.

PMID:
23927644
29.

Cholestatic liver disease.

Jüngst C, Lammert F.

Dig Dis. 2013;31(1):152-4. doi: 10.1159/000347210. Epub 2013 Jun 17. Review.

PMID:
23797137
30.

Two-color glycan labeling of live cells by a combination of Diels-Alder and click chemistry.

Niederwieser A, Späte AK, Nguyen LD, Jüngst C, Reutter W, Wittmann V.

Angew Chem Int Ed Engl. 2013 Apr 8;52(15):4265-8. doi: 10.1002/anie.201208991. Epub 2013 Mar 6. No abstract available.

PMID:
23468318
31.

Locally resolved membrane binding affinity of the N-terminus of α-synuclein.

Robotta M, Hintze C, Schildknecht S, Zijlstra N, Jüngst C, Karreman C, Huber M, Leist M, Subramaniam V, Drescher M.

Biochemistry. 2012 May 15;51(19):3960-2. doi: 10.1021/bi300357a. Epub 2012 Apr 30.

PMID:
22494024
32.

Remodeling of lipid droplets during lipolysis and growth in adipocytes.

Paar M, Jüngst C, Steiner NA, Magnes C, Sinner F, Kolb D, Lass A, Zimmermann R, Zumbusch A, Kohlwein SD, Wolinski H.

J Biol Chem. 2012 Mar 30;287(14):11164-73. doi: 10.1074/jbc.M111.316794. Epub 2012 Feb 6.

33.

Fluorescent conjugated block copolymer nanoparticles by controlled mixing.

Schütze F, Stempfle B, Jüngst C, Wöll D, Zumbusch A, Mecking S.

Chem Commun (Camb). 2012 Feb 18;48(15):2104-6. doi: 10.1039/c2cc17066c. Epub 2012 Jan 13.

PMID:
22246316
34.

Fast and long term lipid droplet tracking with CARS microscopy.

Jüngst C, Winterhalder MJ, Zumbusch A.

J Biophotonics. 2011 Jun;4(6):435-41. doi: 10.1002/jbio.201000120. Epub 2011 Mar 28.

PMID:
21445955
35.

The human organic anion transporter genes OAT5 and OAT7 are transactivated by hepatocyte nuclear factor-1α (HNF-1α).

Klein K, Jüngst C, Mwinyi J, Stieger B, Krempler F, Patsch W, Eloranta JJ, Kullak-Ublick GA.

Mol Pharmacol. 2010 Dec;78(6):1079-87. doi: 10.1124/mol.110.065201. Epub 2010 Sep 9.

PMID:
20829431
36.

Asymmetric PPCys: strongly fluorescing NIR labels.

Fischer GM, Jüngst C, Isomäki-Krondahl M, Gauss D, Möller HM, Daltrozzo E, Zumbusch A.

Chem Commun (Camb). 2010 Aug 7;46(29):5289-91. doi: 10.1039/c0cc00359j. Epub 2010 Jun 11.

PMID:
20539898
37.

Relation of gallbladder motility to viscosity and composition of gallbladder bile in patients with cholesterol gallstones.

Gründel D, Jüngst C, Straub G, Althaus R, Schneider B, Spelsberg FW, Hüttl TP, del Pozo R, Jüngst D, Neubrand M.

Digestion. 2009;79(4):229-34. doi: 10.1159/000213828. Epub 2009 Apr 23.

PMID:
19390195
38.

Properties of the SR Ca-ATPase in an Open Microsomal Membrane Preparation.

A F, C J, H-J A.

Open Biochem J. 2008;2:91-9. doi: 10.2174/1874091X00802010091. Epub 2008 Jun 9.

39.

Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.

Jüngst C, Sreejayan N, Zündt B, Müller I, Spelsberg FW, Hüttl TP, Kullak-Ublick GA, del Pozo R, Jüngst D, von Ritter C.

Eur J Clin Invest. 2008 Sep;38(9):634-9. doi: 10.1111/j.1365-2362.2008.01995.x.

40.

Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma.

Graf H, Jüngst C, Straub G, Dogan S, Hoffmann RT, Jakobs T, Reiser M, Waggershauser T, Helmberger T, Walter A, Walli A, Seidel D, Goke B, Jüngst D.

Digestion. 2008;78(1):34-8. doi: 10.1159/000156702. Epub 2008 Sep 17.

41.

Lipid peroxidation and mucin secretagogue activity in bile of gallstone patients.

Jüngst C, Sreejayan N, Eder MI, von Stillfried N, Zündt B, Spelsberg FW, Kullak-Ublick GA, Jüngst D, von Ritter C.

Eur J Clin Invest. 2007 Sep;37(9):731-6.

PMID:
17696963
42.

Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.

Helmberger T, Dogan S, Straub G, Schrader A, Jüngst C, Reiser M, Waggershauser T, Jakobs T, Hoffmann RT, Löhe F, Graeb C, Rau HG, Schauer R, Jauch KW, Caselmann WH, Göke B, Jüngst D.

Digestion. 2007;75(2-3):104-12. Epub 2007 Jun 26.

PMID:
17598962
43.

Gallstone disease: Microlithiasis and sludge.

Jüngst C, Kullak-Ublick GA, Jüngst D.

Best Pract Res Clin Gastroenterol. 2006;20(6):1053-62. Review.

PMID:
17127187
44.

Effect of gallbladder mucin on the crystallization of cholesterol in bile.

Wilhelmi M, Jüngst C, Mock M, Meyer G, Zündt B, Del Pozo R, Jüngst D.

Eur J Gastroenterol Hepatol. 2004 Nov;16(12):1301-7.

PMID:
15618836
45.

Solubility of cholesterol in the crystal-free gallbladder bile of gallstone patients.

Jüngst D, Gussmann E, Zündt B, Meyer G, Jüngst C, Del Pozo R, Fischer S.

J Lab Clin Med. 2004 Sep;144(3):134-40.

PMID:
15454882
46.

Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects.

Sauter GH, Thiessen K, Parhofer KG, Jüngst C, Fischer S, Jüngst D.

Digestion. 2004;70(2):79-83. Epub 2004 Sep 16.

PMID:
15375335
47.

Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones.

Fischer S, Müller I, Zündt BZ, Jüngst C, Meyer G, Jüngst D.

Eur J Gastroenterol Hepatol. 2004 Mar;16(3):305-11.

PMID:
15195895
48.

Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma.

Jüngst C, Cheng B, Gehrke R, Schmitz V, Nischalke HD, Ramakers J, Schramel P, Schirmacher P, Sauerbruch T, Caselmann WH.

Hepatology. 2004 Jun;39(6):1663-72.

PMID:
15185308
49.

[Potential role of human DNA-repair enzymes hMTH1, hOGG1 and hMYHalpha in the hepatocarcinogenesis].

Cheng B, Jüngst C, Lin J, Caselmann WH.

J Huazhong Univ Sci Technolog Med Sci. 2002;22(3):206-11, 215. German. Retraction in: Cheng B. J Huazhong Univ Sci Technolog Med Sci. 2003;23(3):328.

PMID:
12658805
50.

A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens.

Harabacz I, Bock H, Jüngst C, Klockmann U, Praus M, Weber R.

Vaccine. 1992;10(3):145-50.

PMID:
1557929

Supplemental Content

Loading ...
Support Center